Pediatrics
Unique challenges and complexities of pediatric clinical trials explored.
Identifying and mitigating risks in pediatric protocol development:
Strategies, tools & access planning
In this webinar, presenters will explore the regulatory strategies and tools needed to ensure pediatric access to medical treatment, focusing on Pediatric Investigation Plans (PIPs) and Pediatric Study Plans (PSPs), which are key components in aligning pediatric and adult treatment pathways.
The webinar will also introduce the Pediatric Risk Assessment Map (PRAM), an interactive, reusable tool developed by ICON’s Centre for Pediatric Clinical Development (CPCD).
Pediatric Risk Assessment Map
The Pediatric Risk Assessment Map is an interactive, reusable, and shareable tool that helps to identify common risks that exist in clinical trials that include pediatric patients and offers mitigation strategies for consideration.
The RACE for Children Act
Pediatric cancer is the leading cause of death by disease in the US. The intent of the RACE for Children Act is to get more pediatric oncology drugs in the pipeline.
Pediatrics podcasts
Designing successful pediatric clinical trials
Dr Jacqui Whiteway, Senior Director, Centre for Pediatric Clinical Development took part in this ACRO’s Good Clinical Podcast episode (S2: E4 ) 'Pediatric Clinical Trials: Compassion in Action' to discuss how industry can make participation in pediatric clinical trials easier for pediatric patients and their families.
Removing Barriers to Pediatric Clinical Trials
In this on- demand Podcast. Dr Jacqui Whiteway, Senior Director, Centre for Pediatric Clinical Development discusses something very important to her, ‘Removing Barriers to Pediatric Clinical Trials and how creating positive experiences and reducing anxiety for children in clinical trials can benefit the pediatric trial eco system’. Listen to find out more.
Pediatrics media contributions and blogs
-
Blog: The impact of pediatric medical trauma in clinical trials
Patient-centric pediatric clinical trials can help mitigate the risk of potentially life-long implications of medical trauma and improve trial outcomes.
-
Media article: Accessibility in rare disease paediatric clinical trials
In this International Pharmaceutical Industry article, ICON experts Kirsten Sherman Cervati and William C. Maier discuss strategies to make clinical trials more accessible for Paediatric patients and their families.
-
Blog: Empowering children with education through clinical trials
ICON and Jumo Health have teamed up to share strategies to empower children every day through education, specifically in clinical trials.
-
Blog: Clinical trials through a child’s eyes: writing lay summaries for pediatric trial results
Find out how sponsors can create a PLS that is better understandable to pediatric audiences?
-
Media article: Sharing clinical trial results with paediatric participants
Kirsten Sherman Cervati contributes to this media article which discusses the considerations for returning results to paediatric participants.
Pediatrics services
ICON is invested in bringing safe, effective, pediatric-tested treatments to children. Explore our pediatric experience and how we can support your study from early engagement all the way to approval.